Your browser doesn't support javascript.
loading
A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer.
Zhang, Zheng; Zhang, Yadi; Liu, Chuanling; Shao, Jiakang; Chen, Yimeng; Zhu, Yimin; Zhang, Li; Qin, Boyu; Kong, Ziqing; Wang, Xixi; Wang, Yutong; Huang, Deqin; Liu, Liqun; Zhou, Yuxin; Tao, Ran; Yang, Zengjie; Liu, Mei; Zhao, Weihong.
Affiliation
  • Zhang Z; Medical School of Chinese PLA Beijing China.
  • Zhang Y; Nankai University School of Medicine Tianjin China.
  • Liu C; Medical School of Chinese PLA Beijing China.
  • Shao J; Medical School of Chinese PLA Beijing China.
  • Chen Y; Department of Medical Oncology Xi'an Jiaotong University Xi'an Shaanxi China.
  • Zhu Y; Department of Medical Oncology, Fifth Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
  • Zhang L; Department of Medical Oncology, First Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
  • Qin B; Department of Medical Oncology, Fifth Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
  • Kong Z; Medical School of Chinese PLA Beijing China.
  • Wang X; Nankai University School of Medicine Tianjin China.
  • Wang Y; Medical School of Chinese PLA Beijing China.
  • Huang D; Medical School of Chinese PLA Beijing China.
  • Liu L; Medical School of Chinese PLA Beijing China.
  • Zhou Y; Medical School of Chinese PLA Beijing China.
  • Tao R; Department of Medical Oncology, First Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
  • Yang Z; Cancer Biology Program Fox Chase Cancer Center Philadelphia Pennsylvania USA.
  • Liu M; Department of Pathology, First Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
  • Zhao W; Department of Medical Oncology, First Medical Center General Hospital of the Chinese People's Liberation Army Beijing China.
Cancer Innov ; 2(3): 172-180, 2023 Jun.
Article in En | MEDLINE | ID: mdl-38089401

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Innov Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Innov Year: 2023 Document type: Article Country of publication: